KIST (Korea Institute of Science and Technology)'s US Patent application for "Therapeutic Compounds For Red Blood Cell-Mediated Delivery Of An Active Pharmaceutical Ingredient To A Target Cell" is in published phase now

Press/Media: Press / Media

Period2024 Jun 15

Media coverage

1

Media coverage

  • TitleKIST (Korea Institute of Science and Technology)'s US Patent application for "Therapeutic Compounds For Red Blood Cell-Mediated Delivery Of An Active Pharmaceutical Ingredient To A Target Cell" is in published phase now
    Media name/outletImpact Financial News
    Country/TerritoryUnited Kingdom
    Date24/6/15
    PersonsIn-San Kim
View all 1
View less